ericsphotography / iStockphoto.com
5 March 2018Americas
Helsinn seeks SCOTUS review of patent case
Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
16 February 2017 The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug.
Americas
26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.
Editor's picks
Editor's picks
Americas
16 February 2017 The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug.
Americas
26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.
Americas
16 February 2017 The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug.
Americas
26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.